The biosimilar to reference aflibercept (Eylea, Bayer AG) is indicated to treat retinal diseases including neovascular age-related macular degeneration

A coalition of eye health advocacy groups vocalised support for the legislation

Arun Upadhyay, PhD, discusses new study findings from trials of OCU400 (Ocugen)

HG202, by HuidaGene Therapeutics, is formulated for clinical use in treating neovascular age-related macular degeneration

New analysis brings disease progression and therapeutics into focus

Following oculoplastic surgery, patients who underwent aromatherapy had shorter stays in the post-anesthesia care unit

Collaboration and outside-the-box thinking present significant opportunities for science and industry

This year’s Barcelona meeting brought together award-winning research data and leaders in the retina field

Enhancing cataract surgery with advanced optics

Two glaucoma specialists discuss pairing patients with the right procedures

Caffeine has been shown to temporarily increase intraocular pressure and reduce blood flow in critical ocular regions

Investigators from Bergen, Norway, and Cleveland, Ohio, collaborated on the predictive model

Research indicates suppressive valacyclovir could help patients avoid keratitis and iritis flare-ups

Patients underwent electropuncture, low-intensity laser stimulation of the ciliary muscle, combined therapy and optical-reflex treatment of accommodation

Moving on from medication “stacks” and the old-school reactive approach

The authors reported significant variability in DED-related symptoms, with higher prevalence rates among university students and administrative workers